177 related articles for article (PubMed ID: 33069987)
1. Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.
Fan PL; Ding H; Mao F; Chen LL; Dong Y; Wang WP
Eur J Radiol; 2020 Nov; 132():109341. PubMed ID: 33069987
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
3. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
[TBL] [Abstract][Full Text] [Related]
4. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Early Hepatocellular Carcinoma and High-Grade Dysplastic Nodules on Contrast-Enhanced Ultrasound: Correlation With Histopathologic Findings.
Fan PL; Xia HS; Ding H; Dong Y; Chen LL; Wang WP
J Ultrasound Med; 2020 Sep; 39(9):1799-1808. PubMed ID: 32378794
[TBL] [Abstract][Full Text] [Related]
6. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.
Nicolau C; Catalá V; Vilana R; Gilabert R; Bianchi L; Solé M; Pagés M; Brú C
Eur Radiol; 2004 Jun; 14(6):1092-9. PubMed ID: 15007620
[TBL] [Abstract][Full Text] [Related]
8. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
[TBL] [Abstract][Full Text] [Related]
9. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
13. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.
Jang HJ; Kim TK; Burns PN; Wilson SR
Radiology; 2007 Sep; 244(3):898-906. PubMed ID: 17709836
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
15. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.
Loria F; Loria G; Basile S; Crea G; Randazzo D; Frosina L
Updates Surg; 2012 Dec; 64(4):247-55. PubMed ID: 23055349
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
[TBL] [Abstract][Full Text] [Related]
18. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
[TBL] [Abstract][Full Text] [Related]
19. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.
Xu HX; Lu MD; Liu LN; Zhang YF; Guo LH; Xu JM; Liu C
Br J Radiol; 2012 Oct; 85(1018):1376-84. PubMed ID: 22553290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
